Cargando…
重组人血小板生成素治疗92例成人重型原发免疫性血小板减少症的临床观察
OBJECTIVE: To evaluate the efficacy of recombinant human thrombopoietin (rhTPO) and related factors which influencing the therapeutic effect in adults with severe immune thrombocytopenia (ITP). METHODS: The efficacy of rhTPO in 92 hospitalized adult patients [35 males and 57 females, median age as 3...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342612/ https://www.ncbi.nlm.nih.gov/pubmed/25916293 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.04.011 |
Ejemplares similares
-
重组人血小板生成素在成人原发免疫性血小板减少症患者围手术期的应用
Publicado: (2019) -
重组人血小板生成素治疗41例儿童原发免疫性血小板减少症的疗效及安全性
Publicado: (2015) -
重组人血小板生成素用于原发免疫性血小板减少症维持治疗的有效性和安全性——多中心临床研究
Publicado: (2017) -
大剂量地塞米松联合重组人血小板生成素治疗48例成人初治重症原发免疫性血小板减少症的有效性及安全性
Publicado: (2016) -
重组人血小板生成素对非重型再生障碍性贫血免疫抑制治疗疗效的影响
Publicado: (2020)